(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl)(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)methanone,
cobimetinib,
GDC-0973,
XL518,
Cobimetinib,
934660-93-2,
GDC-0973,
XL518,
Cotellic,
Xl-518,
GDC 0973,
UNII-ER29L26N1X,
XL 518,
RG 7420,
RG7420,
Cobimetinib (GDC-0973, RG7420),
ER29L26N1X,
CHEMBL2146883,
(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl)(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)methanone,
[3,4-Bis(Fluoranyl)-2-[(2-Fluoranyl-4-Iodanyl-Phenyl)amino]phenyl]-[3-Oxidanyl-3-[(2s)-Piperidin-2-Yl]azetidin-1-Yl]methanone,
[3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-phenyl]-((s)-3-hydroxy-3-piperidin-2-yl-azetidin-1-yl)-methanone,
[3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl][3-hydroxy-3-[(2S)-2-piperidinyl]-1-azetidinyl]methanone,
Cobimetinib Butyrate,
Cobimetinib [USAN:INN],
cometinib,
934660-94-3,
AK173907,
EUI,
Cobimetinib (USAN/INN),
SCHEMBL189565,
GTPL7626,
QCR-87,
C21H21F3IN3O2,
CHEBI:90851,
cobimetinib-gdc-0973-rg7420,
DTXSID60239435,
EX-A673,
GDC0973,
BSMCAPRUBJMWDF-KRWDZBQOSA-N,
GDC0973; XL518; Cobimetinib,
3556AH,
BDBM50391802,
MFCD22124461,
s8041,
ZINC60325170,
AKOS025396263,
BCP9000716,
CS-0521,
DB05239,
RG-7421,
VS-0129,
XL518 (GDC-0973),
KS-0000059E,
NCGC00346455-03,
BC600781,
HY-13064,
Methanone, (3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)phenyl)(3-hydroxy-3-((2S)-2-piperidinyl)-1-azetidinyl)-,
AB0072274,
FT-0675878,
D10405,
W-5863,
J-525162,
(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl)(3-hydroxy-3-((S)-piperidin-2-yl)cyclobutyl)methanone,
(S)-(3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)phenyl)(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)methanone,
[3,4-difluoro-2-(2-fluoro-4-iodoanilino)phenyl]{3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl}methanone,
[3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl]-[3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl]methanone,
{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}{3-hydroxy-3-[(2S)-piperidin-2-yl]azetidin-1-yl}methanone,
Cobimetinib Fumarate,
Cobimetinib [USAN],
Cobimetinib (racemate),
Cobimetinib hemifumarate,
D0O2FN,
Cobimetinib (R-enantiomer),
cc-456,
RG-7420,
Cobimetinib, 98% - 25MG 25mg,
A3321,
A3322,
A3323,
A15050,
A15051,
C574276,
934662-91-6,
(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl)(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)methanone,